Valuation: Bayer AG

Market Cap 46.87B 53.61B 43.24B 39.75B 75.31B 5,158B 76.6B 516B 203B 2,521B 201B 197B 8,690B P/E 2026 *
20.6x
P/E 2027 * 15.4x
Enterprise Value 78.71B 90.03B 72.61B 66.75B 126B 8,663B 129B 867B 340B 4,234B 338B 331B 14,594B EV / Sales 2026 *
1.73x
EV / Sales 2027 * 1.62x
Free-Float
100%
Yield 2026 *
0.48%
Yield 2027 * 1.32%
1 day-0.85%
1 week-10.08%
Current month-4.92%
1 month+30.34%
3 months+16.00%
6 months+8.41%
Current year+31.82%
1 week 11.6
Extreme 11.6
12.5
1 month 8.7
Extreme 8.7
13.7
Current year 8.2
Extreme 8.2
13.7
1 year 6
Extreme 6
13.7
3 years 4.38
Extreme 4.38
13.7
5 years 4.38
Extreme 4.38
16.8
10 years 4.38
Extreme 4.38
30.86
Manager TitleAgeSince
Chief Executive Officer 59 2023-05-31
Director of Finance/CFO 57 2026-05-31
Compliance Officer - -
Director TitleAgeSince
Director/Board Member 56 2012-03-31
Director/Board Member 60 2017-03-31
Chairman 68 2020-04-27
Change 5-day change 1-year change 3-year change Capi.($)
-0.85%-10.08% - - 53.61B
+1.66%-3.40%+48.85%+162.91% 1,031B
+1.96%-2.98%+52.55%+58.03% 595B
+3.03%+0.59%+31.91%+86.45% 431B
-0.17%-2.00%+28.34%+22.60% 326B
+0.53%-1.27%+29.02%+44.51% 277B
-0.14%-6.16%+20.08%+22.86% 263B
+2.06%+5.06%-22.43%-37.25% 224B
+2.25%+0.64%+22.38%+60.61% 193B
+1.28%-1.15%+21.34%+72.04% 164B
Average +1.02%-3.79%+25.78%+54.75% 389.37B
Weighted average by Cap. +1.27%-4.31%+34.46%+80.10%

Financials

2026 *2027 *
Net sales 45.6B 52.16B 42.07B 38.67B 73.27B 5,019B 74.53B 502B 197B 2,453B 196B 192B 8,455B 46.76B 53.48B 43.13B 39.65B 75.13B 5,146B 76.41B 515B 202B 2,515B 201B 196B 8,669B
Net income 2.13B 2.43B 1.96B 1.8B 3.42B 234B 3.47B 23.42B 9.19B 114B 9.13B 8.93B 394B 2.93B 3.35B 2.71B 2.49B 4.71B 323B 4.79B 32.3B 12.67B 158B 12.6B 12.32B 544B
Net Debt 31.84B 36.42B 29.37B 27B 51.16B 3,504B 52.04B 351B 138B 1,713B 137B 134B 5,904B 28.71B 32.84B 26.49B 24.35B 46.13B 3,160B 46.92B 316B 124B 1,545B 123B 121B 5,323B
Logo Bayer AG
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (47.5%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (39.1%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.7%). Net sales are distributed geographically as follows: Germany (5.7%), Switzerland (1%), Europe-Middle East-Africa (22.9%), United States (33.1%), North America (3.6%), China (7.6%), Asia-Pacific (8.9%), Brazil (9.6%), and Latin America (7.6%).
Employees
87,757
Date Price Change Volume
26-07-16 11.60 -0.85% 1,632
26-07-15 €11.70 -4.10% 100
26-07-14 €12.20 0.00% 200
26-07-13 €12.20 +1.67% 370
26-07-10 €12.00 -6.98% 1,800
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
47.71EUR
Average target price
54.92EUR
Spread / Average Target
+15.11%

Quarterly revenue - Rate of surprise